GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genotech Corp (XKRX:066830) » Definitions » Research & Development

Genotech (XKRX:066830) Research & Development : ₩367 Mil (TTM As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Genotech Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Genotech's Research & Development for the six months ended in Dec. 2023 was ₩367 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was ₩367 Mil.


Genotech Research & Development Historical Data

The historical data trend for Genotech's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genotech Research & Development Chart

Genotech Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only 333.57 325.48 399.96 345.37 367.10

Genotech Semi-Annual Data
Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only 333.57 325.48 399.96 345.37 367.10

Genotech Research & Development Calculation

This is the expense the company spent on research and development.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was ₩367 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genotech  (XKRX:066830) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Genotech Research & Development Related Terms

Thank you for viewing the detailed overview of Genotech's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Genotech (XKRX:066830) Business Description

Traded in Other Exchanges
N/A
Address
26-69, Gajeongbuk-ro, Yuseong-gu, Daejeon, KOR, 305-343
Genotech Corp is engaged in manufacturing basic pharmaceutical substances and biological agents.

Genotech (XKRX:066830) Headlines

No Headlines